$CGEN 3 SEC Filings

Filed On	Filing
18 Mar 2026	Form 3: Zweifach Sanford S, Director Holds 12,680 shares of Ordinary Shares
18 Mar 2026	Form 3: Silberman David, Chief Financial Officer Holds 35,500 shares of Ordinary Shares
18 Mar 2026	Form 3: Livnat Savitzky Kinneret, Director Holds 13,350 shares of Ordinary Shares
18 Mar 2026	Form 3: Perry Eran, Director Holds 10,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Ophir Eran, Director Holds 11,375 shares of Ordinary Shares
18 Mar 2026	Form 3: Mahler Michelle, Chief Medical Officer Holds 23,125 shares of Ordinary Shares
18 Mar 2026	Form 3: Levine Zurit, SVP, Business Development Holds 29,375 shares of Ordinary Shares
18 Mar 2026	Form 3: Hukkelhoven Mathias, Director Holds 10,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Holcomb Michele, Director Holds 15,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Halevy Gilead, Director Holds 11,407 shares of Ordinary Shares
18 Mar 2026	Form 3: Ferre Pierre, Chief Operating Officer
18 Mar 2026	Form 3: Cohen-Dayag Anat, Director Holds 108,622 shares of Ordinary Shares
18 Mar 2026	Form 3: Kredo Russo Sharon, SVP, Research & Discovery Holds 19,500 shares of Ordinary Shares

Comments